Previous Article | Next Article ![]()
Infection and Immunity, August 2002, p. 4735-4742, Vol. 70, No. 8
0019-9567/02/$04.00+0 DOI: 10.1128/IAI.70.8.4735-4742.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Department of Microbiology, Bose Institute, Calcutta-700 054,1 National Institute of Cholera and Enteric Diseases, Calcutta-700 010, India2
Received 9 October 2001/ Returned for modification 4 March 2002/ Accepted 9 May 2002
| ABSTRACT |
|---|
|
|
|---|
1,000-fold) higher level of CT in vitro compared to that of the parent strain. Virulence gene expression in two other non-O1 non-O139 strains (serogroup O37) containing VPI and the CTX element was studied by RT-PCR and serological assay. One strain (S7, which was involved in an epidemic in Sudan in 1968) showed coordinately regulated expression of virulence genes leading to the production of both CT and TcpA in LB medium. However, the other strain, V2, produced RT-PCR-detectable transcripts of toxT, ctxA, or tcpA genes in the early phase (6 h), but not in the late phase (16 h) of growth in LB medium. These results are consistent with the low levels of production of CT and TcpA by the strain that were serologically detectable. The significance of these results is discussed in relation to the role of virulence genes and their expression to the pathogenic potential of V. cholerae strains belonging to non-O1 serogroups. | TEXT |
|---|
|
|
|---|
(51). Similarly, the tcp gene cluster has been shown to be a part of a 39-kb DNA region, referred to as a vibrio pathogenicity island (VPI), which contains a gene for the ToxT regulatory protein as well as several other clusters of genes of known and unknown function (19). Like CTX, the VPI has been proposed to be of another lysogenic bacteriophage origin (20). The acquisition of VPI by V. cholerae endows the organism with the ability to express TCP, which acts as a receptor for CTX
(20). The VPI and CTX genetic elements are primarily found in V. cholerae strains of O1 and O139 serogroups, which are associated with epidemic cholera (18, 19). The majority of strains belonging to about 200 other non-O1 non-O139 serogroups (53) do not contain genes for CT and/or TCP (18, 31, 47), although the gene for ToxR is ubiquitously present in these strains (34). The non-O1 non-O139 strains, which are predominantly isolated from an aquatic environment, are largely nonpathogenic in nature, although some of these are known to cause sporadic cases or occasional outbreaks of diarrhea in humans (30). Recently, however, ctxAB- and tcp-related genes have been shown to be present in certain strains of non-O1 non-O139 V. cholerae of both clinical and environmental origins (7, 14, 35, 36, 40, 42). This has raised important issues related to their evolution as well as relevance from the public health point of view. The point assumes considerable significance in view of the fact that strains belonging to non-O1 non-O139 serogroups have recently been implicated as the causative agents of a large number of cases of diarrhea in various parts of the world (1, 9, 41, 43). Evidently, documentation of the mere presence of the virulence-associated genes is not likely to provide sufficient information on the pathogenic potential of these strains, which is likely to depend on the presence of complex signaling pathways to couple appropriate environmental signals to virulence gene expression. Although some of the non-O1 non-O139 strains described earlier were shown to express detectable amounts of CT and/or TcpA protein in vitro (10, 14, 31, 32, 35), only limited information about their VPI and CTX is available so far (7, 14, 20), and no data on the regulation of virulence gene expression are available. In an earlier study, we characterized a new type of TcpA protein in a toxigenic V. cholerae strain, 10259, belonging to serogroup O53 (35). In the present communication, we describe partial characterization of VPI and CTX genetic elements of strain 10259 and provide information on its pathogenic potential by determining its ability to express virulence genes when grown in vitro under conditions that favor the expression of the same genes in V. cholerae O1 strains. We have extended this study by including data obtained with two other non-O1 non-O139 strains harboring VPI and CTX-related genes. The bacterial strains and plasmids used in this study are listed in Table 1. The presence of virulence-associated genes in V. cholerae strains was determined by PCR amplification experiments with the primers listed in Table 2. All of these target genes, except toxR, are located in the VPI or CTX genetic element of the V. cholerae chromosome. Bacterial cells were grown overnight in Luria broth (LB) at 37°C, and chromosomal DNA was isolated from the harvested bacteria by a standard protocol. PCR amplification of target DNA was carried out in a thermal cycler (Perkin-Elmer) by essentially following the methodology described earlier (34). The reaction mixture was subjected to 30 cycles of amplification. Each cycle consisted of three successive steps in the following order: denaturation at 94°C for 30 s, annealing at 55°C for 50 s, and extension at 72°C for 50 s.
|
|
|
|
The CTX genetic element of the strain 10259 was also probed with the primers for ctxA, ctxB, zot, ace, orfU, and cep genes, as listed in Table 2. All of these primers produced amplicons of the desired sizes, thereby documenting the presence of these genes in this non-O1 non-O139 strain. Amplicons generated with ctxA and orfU primers were subjected to sequencing analysis, and data were compared with those of O1 strains. The ctxA of 10259 showed only minimum changes from those of classical (0 bp) and El Tor (2 bp) strains. On the other hand, the 10259 orfU sequence diverged significantly from that of the classical strain by 56 bp (9.1% with 14 synonymous and 42 nonsynonymous changes), although it differed from the El Tor orfU by only 8 bp (1.3% with 6 synonymous and 2 nonsynonymous changes).
Recently, orfU has been proposed to be involved in the interaction of CTX
to its receptor TCP on the V. cholerae surface (5). A significant difference between the orfU sequences of classical and El Tor biotype strains was postulated to be responsible for the specific recognition of CTX
s by biotype-specific TcpA proteins, the major structural unit of TCP. Therefore, the fact that the orfU sequence of 10259 shows close similarity to that of El Tor (but not of classical orfU), appears to be somewhat at variance to this concept, since 10259 TcpA was predicted to differ equally from both classical and El Tor TcpA proteins (Table 3). Our results are, however, in agreement with those obtained with certain other non-O1 non-O139 strains, the orfU sequences of which were shown to be more similar to those of El Tor than to those of classical strains (5). At least, two of these strains, 158 and 208, possessed a new variant of TcpA with significant differences from classical, El Tor, as well as 10259 TcpA (35). All of these considerations would suggest that the drift in the TcpA sequence in non-O1 non-O139 V. cholerae strains may not necessarily be related to the need to bind to different OrfU proteins for the acquisition of new type of CTX
. As a matter of fact, TcpA-independent acquisition of CTX
by V. cholerae under selective conditions has been documented recently (4, 13).
Documentation of the presence of VPI and CTX elements in strain 10259 and partial characterization of its virulence-associated genes have prompted us to address the question of their expression in relation to pathogenesis. Therefore, the expression of toxR, tcpP/H, toxT, ctxA, and tcpA genes was studied by reverse transcription-PCR (RT-PCR) with the set of primers listed in Table 1. Briefly, bacterial RNA was extracted with TRIZOL reagent (GIBCO-BRL) from cells grown under the appropriate culture conditions, and the extracted material was treated with RNase-free DNase (Ambion). Purified RNA was used to obtain cDNA. For this, 1 µg of RNA was mixed with 0.1 M dithiothreitol (DTT), 2 pmol of each primer of the primer pair, 10 mM deoxynucleotide triphosphate (dNTP), and 5x first-strand buffer in 9.5 µl of reaction volume, and the mixture was incubated at 42°C for 2 min followed by immediate cooling. Next, 100 U of the enzyme reverse transcriptase (GIBCO-BRL) was added to this mixture, which was incubated at 42°C for 50 min. The reaction was terminated by incubating the mixture at 70°C for 15 min. The cDNA preparation thus obtained was amplified by PCR by the methodology described earlier.
The results obtained in the RT-PCR experiments demonstrate that strain 10259, when grown in LB at pH 6.5 for 16 h at 30°C under mild shaking conditions, expressed transcripts for toxR, tcpP/H, toxT, and tcpA, but not for ctxA (Fig. 2A). Similar results were obtained when the organism was grown in the same LB medium under static conditions or in colonization factor antigen (CFA) agar plates (data not shown). In all of these experiments, the V. cholerae O1 classical strain (O395) was used as the positive control to document the expression of virulence gene-associated transcripts as mentioned above (Fig. 2A). The expression of these genes was also tested by growing strain 10259 in modified AKI medium (52), which is known to favor the expression of ctxAB in El Tor biotype strains. While the control El Tor strain AD48 expressed toxR, tcpP/H, toxT, ctxA, and tcpA when grown in AKI medium at 37°C at pH 7.8 for 4 h under static conditions followed by 2 h of shaking conditions (24), strain 10259 showed expression of toxR with only weakly detectable transcripts of toxT and ctxA, but none for tcpP/H or tcpA (Fig. 2B). Culture of strain 10259 for a longer period (4 h of static conditions plus 6 h of shaking conditions) also failed to produce elevated levels of transcripts for these genes (data not shown).
|
|
pir (29), and ampicillin-resistant transformants were selected. Transformed E. coli cells harboring the recombinant vector pCAS442 were allowed to conjugate with V. cholerae strain 10259 at a donor/recipient ratio of 1:10. Transconjugants of V. cholerae (harboring the chromosomally integrated vector) were selected on thiosulfate-citrate-bile-sucrose (TCBS) agar plates containing ampicillin (50 µg/ml) and checked for their reactivity to the antisera to the O53 serogroup. Next, selected transconjugant colonies were grown on Luria agar (LA) plates containing 10% (wt/vol) sucrose to select organisms to undergo a second recombinational event resulting in the deletion of the suicide vector sequence from the host chromosome. The recombinant colonies thus obtained (10259R) were further checked by their growth requirements, reactivity to O53-specific antisera, and sensitivity to ampicillin. Finally, the chromosomal DNA of 10259R was amplified with the zot-ctxA primer pair, and the product was sequenced to ensure that it contained seven repeats of the heptanucleotide sequence (TTTTGAT) at the proper position. Following characterization, the recombinant strain 10259R was tested for expression of virulence genes by RT-PCR as described earlier. When grown in LB at pH 6.5 at 30°C, the organism was shown to express ctxA in addition to tcpP/H, toxR, toxT, and tcpA (Fig. 2A). However, transcription of tcpP/H, toxT, and ctxA was detectable at low levels only in AKI medium-grown cells of strain 10259R (Fig. 2B). The RT-PCR data were extended through determination of the translated products CT and TcpA. Production of CT was estimated by GM1 enzyme-linked immunosorbent assay (ELISA) (17) with culture supernatants of cells grown under the appropriate culture conditions. While the wild-type strain 10259 produced a barely detectable level of CT in the LB-grown culture supernatant, the recombinant strain 10259R produced a significantly (about 1,000-fold) larger amount of CT in cultures grown under the same conditions (Table 4). In fact, CT produced by 10259R was quite comparable to that produced by the classical strain O395 in LB medium. Production of TcpA was also tested by immunoblotting experiments with a rabbit polyclonal antiserum to the protein. Both the wild-type and recombinant strains expressed TcpA when grown in LB medium, and the level of expression was quite comparable to that of the classical strain O395 grown under the same culture conditions (Fig. 4).
|
|
|
Expression of ctxA in absence of any detectable transcripts of tcpA by strain 10259R in AKI medium raises an interesting question regarding the relative efficiency with which these two genes can be transcriptionally activated in V. cholerae. In a recent study, Yu and DiRita (55) have demonstrated that, although ToxT is the direct activator of both ctxA and tcpA, ctxA transcription regulation is much more complex than that of tcpA. It is also suggested that the ctxA is under the control of a more efficient ToxT-dependent promoter compared to that of tcpA. Thus, under ToxT-limiting conditions, as is the case for strain 10259R grown in AKI medium, expression of ctxA may be achieved even in the absence of a detectable level of tcpA transcripts.
Coordinately regulated expression of CT and TcpA is an essential (although perhaps not sufficient) feature of epidemic-causing strains of V. cholerae, which so far has differentiated them from strains that are not associated with epidemics. Evidently, the genetic background of these strains plays a crucial role in this effect. The emergence of the O139 strain with epidemic potential from an O1 El Tor strain demonstrates that this feature may be retained by a non-O1 strain as well, provided it has a genetic makeup otherwise similar to that of O1 strains (50). Coordinate expression of CT and TcpA in the non-O1 non-O139 V. cholerae strain S7 described here also supports this concept, since this strain was likely to be derived from an O1 classical strain (3) and known to be involved in an epidemic in Sudan in 1968. Results obtained with the genetically engineered strain 10259R, however, demonstrate that coordinate expression of high levels of CT and TcpA is also achievable with a non-O1 non-O139 strain that may not be directly related to an epidemic strain as its origin. Although strain 10259R has shown its pathogenic potential in in vitro experiments, preliminary data generated in our laboratory have demonstrated considerable enhancement of its ability to produce toxin in vivo.
| ACKNOWLEDGMENTS |
|---|
The helpful technical assistance of Prabal Gupta and Debashis Mazumder is acknowledged.
| FOOTNOTES |
|---|
| REFERENCES |
|---|
|
|
|---|
| 1. | Bagchi, K., P. Echeverria, J. D. Arthur, O. Sethabutr, O. Serichantalergs, and C. W. Hoge. 1993. Epidemic diarrhea caused by Vibrio cholerae non-O1 that produced heat-stable toxin among Khmers in a camp in Thailand. J. Clin. Microbiol. 31:1315-1317. |
| 2. | Behari, J., L. Stagon, and S. B. Calderwood. 2001. pepA, a gene mediating pH regulation of virulence genes in Vibrio cholerae. J. Bacteriol. 183:178-188. |
| 3. | Bik, E. M., R. D. Gouw, and F. R. Mooi. 1996. DNA fingerprinting of Vibrio cholerae strains with a novel insertion sequence element: a tool to identify epidemic strains. J. Clin. Microbiol. 34:1453-1461.[Abstract] |
| 4. | Boyd, E. F., and M. K. Waldor. 1999. Alternative mechanism of cholera toxin acquisition by Vibrio cholerae: generalized transduction of CTX by bacteriophage CP-T1. Infect. Immun. 67:5898-5905. |
| 5. | Boyd, E. F., A. J. Heilpern, and M. K. Waldor. 2000. Molecular analysis of a putative CTX precursor and evidence for independent acquisition of distinct CTX s by toxigenic Vibrio cholerae. J. Bacteriol. 182:5530-5538. |
| 6. | Carroll, P. A., K. T. Tashima, M. B. Rogers, V. J. DiRita, and S. B. Calderwood. 1997. Phase variation in tcpH modulates expression of the ToxR regulon in Vibrio cholerae. Mol. Microbiol. 25:1099-1111.[CrossRef][Medline] |
| 7. | Chakraborty, S., A. K. Mukhopadhyay, R. K. Bhadra, A. N. Ghosh, R. Mitra, T. Shimada, S. Yamasaki, S. M. Faruque, Y. Takeda, R. R. Colwell, and G. B. Nair. 2000. Virulence genes in environmental strains of Vibrio cholerae. Appl. Environ. Microbiol. 66:4022-4028. |
| 8. | Chattopadhyaya, R., and A. C. Ghose. 2002. Model of Vibrio cholerae toxin coregulated pilin capable of filament formation. Protein Eng. 15:297-304. |
| 9. | Dalsgaard, A., M. J. Albert, D. N. Taylor, T. Shimada, R. Meza, O. Serichantalergs, and P. Echeverria. 1995. Characterization of Vibrio cholerae non-O1 serogroups obtained from an outbreak of diarrhea in Lima, Peru. J. Clin. Microbiol. 33:2715-2722.[Abstract] |
| 10. | Datta-Roy, K., K. Banerjee, S. P. De, and A. C. Ghose. 1986. Comparative study of expression of hemagglutinins, hemolysins, and enterotoxins by clinical and environmental isolates of non-O1 Vibrio cholerae in relation to their enteropathogenicity. Appl. Environ. Microbiol. 52:875-879. |
| 11. | DiRita, V. J., C. Parsot, G. Jander, and J. J. Mekalanos. 1991. Regulatory cascade controls virulence in Vibrio cholerae. Proc. Natl. Acad. Sci. USA 88:5403-5407. |
| 12. | Donnenberg, M. S., and J. B. Kaper. 1991. Construction of an eae deletion mutant of enteropathogenic Escherichia coli by using a positive-selection suicide vector. Infect. Immun. 59:4310-4317. |
| 13. | Faruque, S. M., Asadulghani, A. R. M. A. Alim, M. J. Albert, K. M. N. Islam, and J. J. Mekalanos.1998. Induction of the lysogenic phage encoding cholera toxin in naturally occurring strains of toxigenic Vibrio cholerae O1 and O139. Infect. Immun. 66:3752-3757. |
| 14. | Ghosh, C., R. K. Nandy, S. K. Dasgupta, G. B. Nair, R. H. Hall, and A. C. Ghose. 1997. A search for cholera toxin (CT), toxin coregulated pilus (TCP), the regulatory element ToxR and other virulence factors in non-O1/non-O139 Vibrio cholerae. Microb. Pathog. 22:199-208.[CrossRef][Medline] |
| 15. | Hase, C. C., and J. J. Mekalanos. 1998. TcpP protein is a positive regulator of virulence gene expression in Vibrio cholerae. Proc. Natl. Acad. Sci. USA 95:730-734. |
| 16. | Heidelberg, J. F., J. A. Eisen, W. C. Nelson, R. A. Clayton, M. L. Gwinn, R. J. Dodson, D. H. Haft, E. K. Hickey, J. D. Peterson, L. Umayam, S. R. Gill, K. E. Nelson, T. D. Read, H. Tettelin, D. Richardson, M. D. Ermolavea, J. Vamathevan, S. Bass, H. Qin, I. Daragoi, P. Sellers, L. McDonald, T. Utterback, R. D. Fleishmann, W. C. Nierman, O. White, S. L. Salzberg, H. O. Smith, R. R. Colwell, J. J. Mekalanos, J. C. Venter, and C. M. Fraser. 2000. DNA sequence of both chromosome of the cholera pathogen Vibrio cholerae. Nature 406:477-484.[CrossRef][Medline] |
| 17. | Holmgren, J. 1973. Comparison of the tissue receptors for Vibrio cholerae and Escherichia coli enterotoxins by means of gangliosides and natural cholera toxoid. Infect. Immun. 8:851-859. |
| 18. | Kaper, J. B., J. G. Morris, Jr., and M. M. Levine. 1995. Cholera. Clin. Microbiol. Rev. 8:48-86.[Abstract] |
| 19. | Karaolis, D. K. R., J. A. Johnson, C. C. Bailey, E. C. Boedeker, J. B. Kaper, and P. R. Reeves. 1998. A Vibrio cholerae pathogenicity island associated with epidemic and pandemic strains. Proc. Natl. Acad. Sci. USA 95:3134-3139. |
| 20. | Karaolis, D. K. R., S. Somara, D. R. Manaeval, Jr., J. A. Johnson, and J. B. Kaper. 1999. A bacteriophage encoding a pathogenicity island, a type-IV pilus and a phage receptor in cholera bacteria. Nature 399:375-379.[CrossRef][Medline] |
| 21. | Karaolis, D. K. R., R. Lan, J. B. Kaper, and P. R. Reeves. 2001. Comparison of Vibrio cholerae pathogenicity islands in sixth and seventh pandemic strains. Infect. Immun. 69:1947-1952. |
| 22. | Kovach, M. E., M. D. Shaffer, and K. M. Peterson. 1996. A putative integrase gene defines the distal end of a large cluster of ToxR-regulated colonization genes in Vibrio cholerae. Microbiology 142:2165-2174.[Abstract] |
| 23. | Krukonis, S. E., R. R. Yu, and V. J. DiRita. 2000. The Vibrio cholerae ToxR/TcpP/ToxT virulence cascade: distinct roles for two membrane-localized transcriptional activators on a single promoter. Mol. Microbiol. 38:67-84.[CrossRef][Medline] |
| 24. | Medrano, A. I., V. J. DiRita, G. Castillo, and J. Sanchez. 1999. Transient transcriptional activation of the Vibrio cholerae El Tor virulence regulator ToxT in response to culture conditions. Infect. Immun. 67:2178-2183. |
| 25. | Mekalanos, J. J. 1983. Duplication and amplification of toxin genes in Vibrio cholerae. Cell 35:253-263.[CrossRef][Medline] |
| 26. | Mekalanos, J. J., D. J. Swartz, G. D. N. Pearson, N. Harford, F. Groyne, and M. de Wilde. 1983. Cholera toxin genes: nucleotide sequence, deletion analysis and vaccine development. Nature 306:551-557.[CrossRef][Medline] |
| 27. | Miller, V. L., and J. J. Mekalanos. 1984. Synthesis of cholera toxin is positively regulated at the transcriptional level by toxR. Proc. Natl. Acad. Sci. USA 81:3471-3475. |
| 28. | Miller, V. L., R. K. Taylor, and J. J. Mekalanos. 1987. Cholera toxin transcriptional activator ToxR is a transmembrane DNA binding protein. Cell 48:271-279.[CrossRef][Medline] |
| 29. | Miller, V. L., and J. J. Mekalanos. 1988. A novel suicide vector and its use in construction of insertion mutations: osmoregulation of outer membrane proteins and virulence determinants in Vibrio cholerae requires toxR. J. Bacteriol. 170:2575-2583. |
| 30. | Morris, J. G., Jr. 1990. Non-O group 1 Vibrio cholerae: a look at the epidemiology of an occasional pathogen. Epidemiol. Rev. 12:179-191. |
| 31. | Morris, J. G., Jr. 1994. Non-O group 1 Vibrio cholerae strains not associated with epidemic disease, p. 103-115. In I. K. Wachsmuth, P. A. Blake, and Ø. Olsvik (ed.), Vibrio cholerae and cholera: molecular to global perspectives. ASM Press, Washington, D.C. |
| 32. | Mukhopadhyay, A. K., P. K. Saha, S. Garg, S. K. Bhattacharya, T. Shimada, T. Takeda, Y. Takeda, and G. B. Nair. 1995. Distribution and virulence of Vibrio cholerae belonging to serogroups other than O1 and O139: a nation survey. Epidemiol. Infect. 114:65-70.[Medline] |
| 33. | Mukhopadhyay, A. K., S. Chakraborty, Y. Takeda, G. B. Nair, and D. E. Berg. 2001. Characterization of VPI pathogenicity island and CTX prophage in environmental strains of Vibrio cholerae. J. Bacteriol. 183:4737-4746. |
| 34. | Nandi, B., R. K. Nandy, S. Mukhopadhyay, G. B. Nair, T. Shimada, and A. C. Ghose. 2000. Rapid method for species-specific identification of Vibrio cholerae using primers targeted to the gene of outer membrane protein OmpW. J. Clin. Microbiol. 38:4145-4151. |
| 35. | Nandi, B., R. K. Nandy, A. C. P. Vicente, and A. C. Ghose. 2000. Molecular characterization of a new variant of toxin-coregulated pilus protein (TcpA) in a toxigenic non-O1/non-O139 strain of Vibrio cholerae. Infect. Immun. 68:948-952. |
| 36. | Novais, R. C., A. Coelho, C. A. Salles, and A. C. Vicente. 1999. Toxin-co-regulated pilus cluster in non-O1, non toxigenic Vibrio cholerae: evidence of a third allele of pilin gene. FEMS Microbiol. Lett. 171:49-55.[CrossRef][Medline] |
| 37. | Ogierman, M. A., E. Voss, C. Meaney, R. Faast, R. Attridge, and P. A. Manning. 1996. Comparison of the promoter proximal regions of the toxin coregulated tcp gene cluster in classical and El Tor strains of Vibrio cholerae O1. Gene 170:9-16.[CrossRef][Medline] |
| 38. | Pearson, G. D. N., A. Woods, S. L. Chiang, and J. J. Mekalanos. 1993. CTX genetic element encodes a site specific recombination system and an intestinal colonization factor. Proc. Natl. Acad. Sci. USA 90:3750-3754. |
| 39. | Pfau, J. D., and R. K. Taylor. 1996. Genetic footprint of the ToxR-binding site in the promoter for cholera toxin. Mol. Microbiol. 20:213-222.[Medline] |
| 40. | Rivera, I. N. G., J. Chun, A. Huq, R. B. Sack, and R. R. Colwell. 2001. Genotypes associated with virulence in environmental isolates of Vibrio cholerae. Appl. Environ. Microbiol. 67:2421-2429. |
| 41. | Rudra, S., R. Mahajan, M. Mathur, K. Kathuria, and V. Talwar. 1996. Cluster of cases of clinical cholera due to Vibrio cholerae O10 in east Delhi. Indian J. Med. Res. 103:71-73.[Medline] |
| 42. | Said, B., H. R. Smith, S. M. Scotland, and B. Rowe. 1995. Detection and differentiation of the gene for toxin co-regulated pili (tcpA) in Vibrio cholerae non-O1 using the polymerase chain reaction. FEMS Microbiol. Lett. 125:205-210.[CrossRef][Medline] |
| 43. | Sharma, C., M. Thungapathra, A. Ghosh, A. K. Mukhopadhyay, A. Basu, R. Mitra, I. Basu, S. K. Bhattacharya, T. Shimada, T. Ramamurthy, T. Takeda, S. Yamasaki, Y. Takeda, and G. B. Nair. 1998. Molecular analysis of non-O1, non-O139 Vibrio cholerae associated with an unusual upsurge in the incidence of cholera like disease in Calcutta, India. J. Clin. Microbiol. 36:756-763. |
| 44. | Shuman, S. 1994. Novel approach to molecular cloning and polynucleotide synthesis. J. Biol. Chem. 269:32678-32684. |
| 45. | Skorupski, K., and R. K. Taylor. 1997. Control of the ToxR virulence regulon in Vibrio cholerae by environmental stimuli. Mol. Microbiol. 25:1003-1009.[CrossRef][Medline] |
| 46. | Skorupski, K., and R. K. Taylor. 1999. A new level in the Vibrio cholerae ToxR virulence cascade: AphA is required for transcriptional activation of the tcpPH operon. Mol. Microbiol. 31:763-771.[CrossRef][Medline] |
| 47. | Taylor, R., C. Shaw, K. Peterson, P. Spears, and J. Mekalanos. 1988. Safe, live Vibrio cholerae vaccines? Vaccine 6:151-154.[CrossRef][Medline] |
| 48. | Taylor, R. K., V. L. Miller, D. B. Furlong, and J. J. Mekalanos. 1987. Use of phoA gene fusions to identify a pilus colonization factor coordinately regulated with cholera toxin. Proc. Natl. Acad. Sci. USA 84:2833-2837. |
| 49. | Voss, E., P. A. Manning, and S. T. Attridge. 1996. The toxin-coregulated pilus is a colonization factor and protective antigen of Vibrio cholerae El Tor. Microb. Pathog. 20:141-153.[CrossRef][Medline] |
| 50. | Waldor, M. K., and J. J. Mekalanos. 1994. ToxR regulates virulence gene expression in non-O1 strains of Vibrio cholerae that cause epidemic cholera. Infect. Immun. 62:72-78. |
| 51. | Waldor, M. K., and J. J. Mekalanos. 1996. Lysogenic conversion by a filamentous phage encoding cholera toxin. Science 272:1910-1914.[Abstract] |
| 52. | Waldor, M. K., E. J. Rubin, G. D. N. Pearson, H. Kimsey, and J. J. Mekalanos. 1997. Regulation, replication, and integration functions of the Vibrio cholerae CTX are encoded by region RS2. Mol. Microbiol. 24:917-926.[CrossRef][Medline] |
| 53. | Yamai, S., T. Okitsu, T. Shimada, and Y. Katsube. 1997. Distribution of serogroups of Vibrio cholerae nonO1/nonO139 with specific reference to their ability to produce cholera toxin and addition of novel serogroups. Jpn. J. Assoc. Infect. Dis. 71:1037-1045. |
| 54. | Yu, R. R., and V. J. DiRita. 1999. Analysis of an autoregulatory loop controlling ToxT, cholera toxin, and toxin-coregulated pilus production in Vibrio cholerae. J. Bacteriol. 181:2584-2592. |
| 55. | Yu, R. R., and V. J. DiRita. 2002. Regulation of gene expression in Vibrio cholerae by ToxT involves both the antirepression and RNA polymerase stimulation. Mol. Microbiol. 43:119-134.[CrossRef][Medline] |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|